How to Read Quantitative Veterinary Test Results

Q: What is a reference range and how do I use it?

A reference range is the interval of values expected in healthy animals, typically the central 95% of a healthy population. A value outside the range suggests abnormality, but reference ranges are population-based — always interpret the number in the context of the individual patient, its history and its clinical signs.

Q: What is the difference between a reference range and a cut-off?

A reference range describes a healthy population. A cut-off is a clinical decision threshold — the value above which a specific action is indicated. For example, cPL ≥400 µg/L is consistent with pancreatitis, while the reference interval for healthy dogs is <200 µg/L.

Q: What does CV (coefficient of variation) mean on a test result?

The coefficient of variation measures precision — how much repeated measurements of the same sample vary. A CV below 10% means results are tightly reproducible, which is what makes serial trend monitoring meaningful.

Q: What is the difference between LOD and a reference range?

The limit of detection (LOD) is the lowest concentration the assay can reliably distinguish from zero. The reference range is the interval of values seen in healthy animals. LOD is about analytical sensitivity; the reference range is about clinical normality.

Q: What is an equivocal zone?

A grey band between clearly normal and clearly abnormal. For cPL, 201–400 µg/L is equivocal and warrants re-testing in 2–3 weeks. A quantitative result is what lets you recognise an equivocal zone and respond with re-testing instead of a premature diagnosis.

Q: How do I interpret a borderline result?

A value near the upper end of the reference range, or just over it, is often the earliest sign of developing disease — but it's also where pre-analytical noise lives. Confirm with re-measurement and integrate with the clinical picture rather than over-reacting to a single point.

TL;DR: A number only becomes a diagnosis when you know 2 contexts: the reference range and the cut-off. Learn the equivocal zones — cPL 201–400 µg/L — and trust a trend only when CV is below 10%. Then read the number against the individual patient, not the population average.

A quantitative test result is a number — but a number only becomes a diagnosis when you know how to read it. This guide covers the concepts that govern interpretation: the reference range, clinical cut-offs, equivocal zones, the coefficient of variation (CV), and the limit of detection (LOD) — plus the errors that turn a good number into a bad decision.

The Reference Range: Normal Is a Range, Not a Point

A reference range is the interval of values expected in a healthy population — conventionally the central 95% of healthy animals. A value above or below the range suggests abnormality.

Three things to remember:

They are population-based, not patient-based. A value inside the range does not prove health, and a value just outside it does not prove disease. Interpret the number against the individual patient — age, breed, body condition, history, clinical signs.
They are species- and sometimes age-specific. A range validated for adult dogs may not apply to puppies. The IDEXX SDMA reference interval is a concrete example: 0–14 µg/dL for adult dogs and cats, but 0–16 µg/dL for puppies.
Borderline values deserve rechecking. A value sitting at the upper end of the range is often the earliest sign of developing disease — and a single borderline result is best confirmed by re-measurement rather than over-interpretation.

Cut-Offs: Where a Number Becomes a Decision

A cut-off is different from a reference range. The reference range describes a healthy population; a cut-off is a clinical decision threshold — the value above which a specific action is indicated.

The markers where quantitative testing earns its keep are exactly the ones with well-established cut-offs:

Marker	Reference / normal	Equivocal	Action threshold
cPL	<200 µg/L	201–400 µg/L	≥400 µg/L (pancreatitis)
NT-proBNP (dog)	<500 pmol/L	500–1,100 pmol/L	>1,725 pmol/L (CHF likely)
SDMA (adult dog/cat)	≤14 µg/dL	15–19 µg/dL	≥20 µg/dL (kidney disease probable)

These thresholds come from manufacturer validation and the peer-reviewed literature (see References). The point for day-to-day reading: a number is only clinically useful if you know which side of the cut-off it falls on — and whether it’s in an equivocal band in between.

The Equivocal Zone: Where Over-Reading Happens

Between “normal” and “abnormal” sits a grey band. The cPL assay illustrates it cleanly:

<200 µg/L — within reference interval.
201–400 µg/L — equivocal. Re-test in 2–3 weeks.
≥400 µg/L — consistent with pancreatitis.

The equivocal zone exists because biology is continuous. The most common interpretation error is treating an equivocal value as diagnostic — committing to a pancreatitis or cardiac diagnosis from a number that actually says “recheck.” A quantitative result is what makes the equivocal zone visible at all, so you can respond with re-testing instead of a premature call.

CV: Can You Trust the Trend?

The coefficient of variation (CV) measures precision — how much repeated measurements of the same sample scatter around the mean. A CV below 10% means the assay is tightly reproducible; a higher CV means more scatter.

CV matters because of what quantitative testing is for: trend monitoring. You’re watching a biomarker fall as a patient recovers, or rise as disease progresses. That trend is only meaningful if the change between two measurements is larger than the noise between two runs of the same sample.

The practical rule: before you call a change “real,” it should exceed the assay’s known variability. A well-run quantitative immunoassay (CV < 10%) gives you a measurement stable enough to distinguish true change from noise — which is why precision, not just sensitivity, is a headline specification on any quantitative analyzer.

LOD: How Low Can It See?

The limit of detection (LOD) is the lowest concentration the assay can reliably distinguish from zero. Modern fluorescence immunoassay reaches picogram-per-millilitre sensitivity for many analytes.

LOD matters for early detection and subtle change. If you want to catch a biomarker as it begins to rise — long before it’s grossly abnormal — the assay must be able to see very small concentrations. A high LOD reports “zero” or “below range” even when a meaningful trace amount is present. Sensitivity and LOD are what make early detection possible.

Common Interpretation Errors

1. Treating the reference range as a verdict. Just inside the range is not “all clear,” and just outside is not “diseased.” Reference ranges are statistical boundaries, not clinical ones.

2. Ignoring pre-analytical factors. The best assay can’t fix a bad sample. Haemolysis, lipaemia, wrong sample type, delayed processing, and improper storage all shift results. When a number doesn’t match the patient, question the sample before questioning the assay.

3. Over-reading a single value. One number is a snapshot. Two or three, taken over time, are a story. For quantitative biomarkers, the trajectory is usually more informative than any single point.

4. Confusing precision with accuracy. A precise assay gives reproducible results (low CV); an accurate assay gives results close to the true value. They’re not the same. A precise-but-inaccurate instrument reproduces its error consistently — which is why calibration against standards matters.

A Practical Reading Sequence

When a quantitative result lands in front of you:

Check the units and the species-appropriate reference range.
Consider the sample — was it collected, handled and timed correctly?
Locate the cut-off — is this value normal, equivocal, or action-threshold?
Look for a trend — is there a previous value to compare against?
Integrate with the patient — does the number fit the clinical picture?
When borderline, recheck rather than over-react.

Application & Commercial Angle

Who should care: clinics and lab staff who must trust the number on the screen. The buyer case is that a quantitative analyzer is only as valuable as the staff’s ability to read reference ranges, cut-offs and CV.

In practice, training on interpretation protects the analyzer investment and turns raw numbers into same-visit clinical decisions.

FAQ

What is a reference range and how do I use it?

A reference range is the interval of values expected in healthy animals, typically the central 95% of a healthy population. A value outside suggests abnormality, but always interpret it against the individual patient, history and clinical signs.

What is the difference between a reference range and a cut-off?

A reference range describes healthy animals; a cut-off is a decision threshold — for example, cPL ≥400 µg/L means pancreatitis while the healthy reference is <200 µg/L.

What does CV (coefficient of variation) mean on a test result?

The coefficient of variation is 1 precision metric — how much repeated measurements of the same sample vary. A CV below 10% means results are tightly reproducible, which is what makes serial trend monitoring meaningful.

What is the difference between LOD and a reference range?

The limit of detection (LOD) is the lowest concentration the assay can distinguish from zero; the reference range is the interval seen in healthy animals — 2 different concepts.

What is an equivocal zone?

An equivocal zone is a grey band — cPL 201–400 µg/L is neither normal nor diagnostic and warrants re-testing in 2–3 weeks.

How do I interpret a borderline result?

1 borderline value is often the earliest sign of developing disease — but it’s also where pre-analytical noise lives. Confirm with re-measurement rather than reacting to 1 point.

Key Takeaways

Know the reference range for species and life stage — SDMA 14 vs 16 µg/dL for adults vs puppies.
Cut-offs are decision thresholds — cPL ≥400 µg/L means pancreatitis, distinct from the healthy <200 µg/L range.
Equivocal zones are where over-reading happens — cPL 201–400 µg/L means re-test, not diagnose.
Trust a trend only when CV <10% supports it.
LOD governs early detection — 1 trajectory of serial results matters more than any single point.

References

McCord K, et al. Spec cPL for Diagnosis of Canine Pancreatitis. Clinician’s Brief. https://www.cliniciansbrief.com/article/spec-cpl-diagnosis-canine-pancreatitis
Raffan E, et al. The Cardiac Biomarker NT-proBNP Is Increased in Dogs. J Vet Intern Med. 2009. doi:10.1111/j.1939-1676.2009.0373.x
IDEXX Laboratories. Interpreting SDMA Test Results for Cats and Dogs. https://www.idexx.com/en/veterinary/reference-laboratories/sdma/interpreting-your-sdma-results
IRIS (International Renal Interest Society). CKD Guidelines. 2015.

This content is for educational and product-selection purposes only. It is not a substitute for veterinary diagnosis — any animal with suspected disease should be evaluated by a veterinarian. Reference ranges are assay-dependent; always use your analyzer’s validated intervals. Product specifications are as published by Migibio (Guangzhou Magic Biotech Co., Ltd.) and may change.